Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.12.23.630096

Role of surface negative charges in agonist binding to the unliganded open state of the neuromuscular acetylcholine receptor

Abstract

Acetylcholine receptors (AChRs) expressed at the nerve muscle junction (NMJ) synapses are hetero-pentameric ligand-gated ion channels with two neurotransmitter binding sites (TBS) at -{delta} and -{varepsilon} (adult)/{gamma} (fetal) subunit interfaces. They are typical allosteric proteins which reside in at least two stable conformations: resting (Closed) and active (Open) states. Mechanism of agonist (A) binding to the C state has been extensively studied, but agonist association to the O state has not been clearly understood. Here, by using engineered constitutively active AChRs, single-channel patch-clamp, and molecular dynamics (MD) simulations, we elucidate the differences between unliganded (O) vs liganded (AO) active states and the mechanism of agonist association to the O state. Our results indicate that: 1. At the {gamma}-binding site, for a series of agonists, the O state agonist association rate (jon) was [~]30 times faster than the diffusion limit and agonist affinity was 2-orders of magnitude higher vs at the {delta}- and {varepsilon}-binding sites. 2. Electrostatic surface charge density owing to 4 negatively charged residues ({gamma}E57, {gamma}D113, {gamma}D174, and {gamma}E180) facilitates loop C capping, compaction of the TBS, and agonist stabilization in the AO state. 3. Mutating these residues in combination reversed the jon and binding affinity to those comparable to the {delta}- and {varepsilon}-binding sites. 4. {varphi}-value analysis indicated the presence of a transition state intermediate between the O and AO states. Overall, we elucidate the role of neighboring charged residues outside the TBS in determining high-affinity agonist binding and their significance in shaping the synaptic response at the NMJ. SummaryNicotinic acetylcholine receptors (AChRs) are allosteric proteins that are crucial for muscle contraction. The isomerization of resting closed (C) to active open (O) state can be achieved by both bind-gate and gate-bind (rare) pathway. Little is known about agonist binding to the unliganded functional O state. Here, we elucidate the nature of unliganded O state and the mechanism of agonist binding to this high-affinity O state by single-channel current recordings, protein engineering, in silico methods and phi-analysis. Our results describe an energetic barrier between the unliganded and liganded O state owing to negatively charged amino acids near the agonist site. These charges partially contribute to the low- and high-affinity agonist energies specifically at the embryonic neurotransmitter binding site. We also discussed the physiological significance of these residues in shaping synaptic response. Significance StatementEmbryonic-type AChRs are indispensable for nerve-muscle junction formation. Many mutations in these receptors cause congenital myasthenia syndrome by increasing constitutive channel activation. Therefore, understanding the nature of unliganded functional open (O) state is critical. Here, we describe the nature and the mechanism of agonist binding to the unliganded O (or apo) state. Single-channel currents were recorded with different background constructs and binding site mutations. The results highlight the importance of loop C and ligand orientation in determining high-affinity agonist binding. Further we elucidate the role of electrostatic interactions in agonist binding to the O state (high-affinity binding). We surmise that higher association rate of agonist binding to O state is the reason behind higher efficacy of the fetal receptor.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Khatoon, N., Nayak, T. K.. 2024-12-24. Role of surface negative charges in agonist binding to the unliganded open state of the neuromuscular acetylcholine receptor. https://doi.org/10.1101/2024.12.23.630096

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Mechanism of molecular recognition revealed through dynamic drug binding pathways to SARS-CoV-2 main protease

Characterization of drug-binding pathways remains experimentally limited by transient intermediates and computationally challenging due to long timescales intractable for conventional molecular dynamics. To address these challenges, we combined solution NMR titrations with weighted ensemble (WE) enhanced sampling simulations to resolve atomistic pathways of nirmatrelvir binding to the SARS-CoV-2 main protease. NMR titration revealed residue-dependent heterogeneity spanning fast, intermediate, and slow exchange regimes. WE simulations complement the NMR by providing insights into unassigned residues and adding time-resolved and three-dimensional structural context. We map key interactions along two distinct binding pathways, provide dynamic explanations for residues involved in resistance, and capture unique backbone conformations compared to those sampled in unbound or bound states. Our comprehensive binding model is consistent with a combined conformational selection and induced fit mechanism in which early transient contacts are made with residues E47 and L50 and allosteric motions are centered around residue V204 of the distal domain. This synergistic application of WE and titration NMR enables a more comprehensive characterization of drug binding than either method alone, providing an integrated framework that may have broader applicability to defining structure-kinetic relationships and guiding design of next-generation inhibitors.

biophysics↗

Discriminating betacoronavirus receptor usage across subgenera using protein structure prediction and molecular dynamics

A critical step in the emergence of a virus is the ability of the viral protein to bind a host receptor and mediate cell entry. For many coronaviruses, this interaction occurs between the Spike S1 subunit and the human ACE2 receptor. Whether this binding interface can be computationally distinguished across unstudied viruses without experimentally resolved protein structures remains an open question. We predicted how 28 emerging coronaviruses may bind to human ACE2 using structural predictions, static interaction prediction programs, and molecular dynamics simulations. To screen the emerging coronaviruses, we predicted a library of S1 structures using AlphaFold. These predicted structures were then used to model the S1-ACE2 interaction with AlphaFold, ClusPro, and HADDOCK. We used known ACE2-binding sarbecoviruses as positive controls and coronaviruses that bind other receptors as negative controls to threshold predicted binding. Contact analysis quantified the predicted binding and revealed that these static interaction prediction methods varied in discriminative power. Less restrained static predictions separated binders from non-binders, whereas heavily restrained docking did not, potentially forcing an interaction where none should exist. This analysis highlighted an emerging coronavirus, Zhejiang2013, as a potential ACE2 binder. We used molecular dynamics simulations to further assess the static predictions and model the interaction over time. Overall, our results indicate that Zhejiang2013 exhibits dynamic interaction patterns consistent with ACE2 binding. Given that two ACE2-binding coronaviruses have caused global pandemics within the past two decades, identifying potential ACE2 binders is critical for early warning and pandemic preparedness.

biophysics↗

De novo design of flexible protein interactions with GuideFlip

De novo design of protein binders requires a target structure. However, for flexible targets, such as intrinsically disordered proteins, this structure does not exist until the binder has stabilized the interaction. Such targets are therefore difficult for methods that separate structure generation from sequence design. We introduce GuideFlip, which co-designs structure and sequence through guided discrete flow matching: binder residues are assigned progressively while the complex is re-predicted at each step, allowing the evolving interface to affect the design process. GuideFlip reduces the hydrophobic bias of direct AlphaFold optimization and improves in silico success rates over existing approaches. We release a database of binder candidates for 177 human disordered proteins. Experimentally, we obtain de novo binders to the C-terminus of -synuclein and the disordered amino terminus of RBX1 with hit rates of 13.5% and 41.7%, respectively, and we confirm the epitopes of selected binders by NMR and mutagenesis. Applying GuideFlip to flexibility on the binder side, we design a nanobody that binds the agonist-bound {beta}1-adrenergic receptor in the active state, but not the receptor in its inactive state, with a 75% hit rate and cryo-EM structure confirming the design. GuideFlip enables protein design where bound structures emerge only upon binding.

biophysics↗